The Filing Desk

ImmuCell vs VolitionRx

ImmuCell ICCC · VolitionRx VNRX · Health Care Supplies

ImmuCell reported revenue of $28 million in fiscal 2025, 16.2 times VolitionRx's $2 million in fiscal 2025. ImmuCell's revenue grew 4.3% in its latest year, and VolitionRx's grew 40.0%. ImmuCell had an operating margin of 6.0%, against -1258.5% at VolitionRx. Free cash flow was $1 million at ImmuCell and −$20 million at VolitionRx.

Side by side

ImmuCellVolitionRx
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$28M$2M
Revenue growth4.3%40.0%
Revenue growth a year, last 5 years12.5%—
Gross margin41.4%—
Operating margin6.0%−1,258.5%
Net margin−3.8%−1,352.2%
Free cash flow$1M−$20M
Free cash flow margin4.4%−1,144.7%
Return on capital——
Net debt to EBITDA1.2x—
Dividends and buybacks$0M$0M
Change in diluted share count10.5%23.5%
Last close$11.17$0.16
P/E at the last close58.8×—
Insider trades, last 12 monthsbought $140,146, sold $0—
Piotroski F-score—2 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ImmuCellVolitionRx
Operating margin
Percent of revenue
ImmuCellVolitionRx
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ImmuCellVolitionRx

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ImmuCell and VolitionRx pages.